Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.

Lodise TP, Turner NA, Hamasaki T, Fishbane N, Ghazaryan V, Wall A, Ge L, Wu Q, Zeng L, Riccobene T, Patel R, Zaharoff S, Rappo U, Evans S, Fowler VG Jr, Chambers HF, Holland TL, Antibacterial Resistance Leadership Group

Open source

DOI: 10.1001/jamanetworkopen.2026.11652
Published: 2026 Apr 1
Container: JAMA network open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2026.11652,
  title = {Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.},
  author = {Lodise TP and Turner NA and Hamasaki T and Fishbane N and Ghazaryan V and Wall A and Ge L and Wu Q and Zeng L and Riccobene T and Patel R and Zaharoff S and Rappo U and Evans S and Fowler VG Jr and Chambers HF and Holland TL and Antibacterial Resistance Leadership Group},
  year = {2026},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2026.11652},
  url = {https://doi.org/10.1001/jamanetworkopen.2026.11652}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.
AU  - Lodise TP
AU  - Turner NA
AU  - Hamasaki T
AU  - Fishbane N
AU  - Ghazaryan V
AU  - Wall A
AU  - Ge L
AU  - Wu Q
AU  - Zeng L
AU  - Riccobene T
AU  - Patel R
AU  - Zaharoff S
AU  - Rappo U
AU  - Evans S
AU  - Fowler VG Jr
AU  - Chambers HF
AU  - Holland TL
AU  - Antibacterial Resistance Leadership Group
PY  - 2026
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2026.11652
UR  - https://doi.org/10.1001/jamanetworkopen.2026.11652
ER  -

APA

TP, L., NA, T., T, H., N, F., V, G., A, W., L, G., Q, W., L, Z., T, R., R, P., S, Z., U, R., S, E., Jr, F. V., HF, C., TL, H., & Group, A. R. L. (2026). Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2026.11652

Source records

pubmed · retrieved 2026-09-26T22:34:27.952Z